185 related articles for article (PubMed ID: 26714738)
21. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.
Laustsen JK; Rasmussen TK; Stengaard-Pedersen K; Hørslev-Petersen K; Hetland ML; Østergaard M; Junker P; Hvid M; Deleuran B
Arthritis Res Ther; 2014 Oct; 16(5):474. PubMed ID: 25359291
[TBL] [Abstract][Full Text] [Related]
22. Etanercept increases tumor necrosis factor-alpha level but not sFas level in patients with rheumatoid arthritis.
Kotyla P; Jankiewicz-Ziobro K; Owczarek A; Kucharz EJ
Isr Med Assoc J; 2015 Jan; 17(1):14-8. PubMed ID: 25739170
[TBL] [Abstract][Full Text] [Related]
23. Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis.
Blaschke S; Viereck V; Schwarz G; Klinger HM; Guerluek S; Müller GA
Scand J Rheumatol; 2009; 38(4):235-9. PubMed ID: 19247848
[TBL] [Abstract][Full Text] [Related]
24. Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors.
Berg L; Lampa J; Rogberg S; van Vollenhoven R; Klareskog L
Ann Rheum Dis; 2001 Feb; 60(2):133-9. PubMed ID: 11156546
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.
Xiong YS; Cheng Y; Lin QS; Wu AL; Yu J; Li C; Sun Y; Zhong RQ; Wu LJ
Rheumatology (Oxford); 2014 Feb; 53(2):250-9. PubMed ID: 24196391
[TBL] [Abstract][Full Text] [Related]
26. [Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
Bombardieri S; Ferraccioli G; Ferri C; Galeazzi M; Lapadula G; Cerinic MM; Montecucco C; Triolo G; Trotta F; Valentini G
Reumatismo; 2009; 61 Suppl 1():1-23. PubMed ID: 19999184
[TBL] [Abstract][Full Text] [Related]
27. TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis.
Barbati C; Vomero M; Colasanti T; Diociaiuti M; Ceccarelli F; Ferrigno S; Finucci A; Miranda F; Novelli L; Perricone C; Spinelli FR; Truglia S; Conti F; Valesini G; Alessandri C
Arthritis Res Ther; 2018 Dec; 20(1):273. PubMed ID: 30526655
[TBL] [Abstract][Full Text] [Related]
28. Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1beta production and deficient apoptosis of rheumatoid arthritis monocytes.
Meusch U; Rossol M; Baerwald C; Hauschildt S; Wagner U
Arthritis Rheum; 2009 Sep; 60(9):2612-21. PubMed ID: 19714631
[TBL] [Abstract][Full Text] [Related]
29. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis.
van Roon JA; Hartgring SA; Wenting-van Wijk M; Jacobs KM; Tak PP; Bijlsma JW; Lafeber FP
Ann Rheum Dis; 2007 May; 66(5):664-9. PubMed ID: 17185327
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab.
Mitoma H; Horiuchi T; Tsukamoto H; Tamimoto Y; Kimoto Y; Uchino A; To K; Harashima S; Hatta N; Harada M
Arthritis Rheum; 2008 May; 58(5):1248-57. PubMed ID: 18438840
[TBL] [Abstract][Full Text] [Related]
31. Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy.
Chen YM; Chang CY; Chen HH; Hsieh CW; Tang KT; Yang MC; Lan JL; Chen DY
Arthritis Res Ther; 2018 Dec; 20(1):268. PubMed ID: 30518408
[TBL] [Abstract][Full Text] [Related]
32. Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritis.
Wendling D; Abbas W; Godfrin-Valnet M; Kumar A; Guillot X; Khan KA; Vidon C; Coquard L; Toussirot E; Prati C; Herbein G
PLoS One; 2015; 10(3):e0119981. PubMed ID: 25799392
[TBL] [Abstract][Full Text] [Related]
33. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
[TBL] [Abstract][Full Text] [Related]
34. Modern treatment strategies in rheumatoid arthritis.
Hetland ML
Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
[TBL] [Abstract][Full Text] [Related]
35. Disease activity improvement in rheumatoid arthritis treated with tumor necrosis factor-α inhibitors correlates with increased soluble Fas levels.
Romano E; Terenzi R; Manetti M; Peruzzi F; Fiori G; Nacci F; Bellando-Randone S; Matucci-Cerinic M; Guiducci S
J Rheumatol; 2014 Oct; 41(10):1961-5. PubMed ID: 25179850
[TBL] [Abstract][Full Text] [Related]
36. Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients.
Damen MSMA; Schraa K; Tweehuysen L; den Broeder AA; Netea MG; Popa CD; Joosten LAB
Sci Rep; 2018 Sep; 8(1):14050. PubMed ID: 30232372
[TBL] [Abstract][Full Text] [Related]
37. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis.
Iagnocco A; Finucci A; Ceccarelli F; Perricone C; Iorgoveanu V; Valesini G
Rheumatology (Oxford); 2015 Oct; 54(10):1890-6. PubMed ID: 26070937
[TBL] [Abstract][Full Text] [Related]
38. Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis.
Nissinen R; Leirisalo-Repo M; Peltomaa R; Palosuo T; Vaarala O
Ann Rheum Dis; 2004 Jun; 63(6):681-7. PubMed ID: 15140775
[TBL] [Abstract][Full Text] [Related]
39. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
[TBL] [Abstract][Full Text] [Related]
40. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.
Brennan FM; Hayes AL; Ciesielski CJ; Green P; Foxwell BM; Feldmann M
Arthritis Rheum; 2002 Jan; 46(1):31-41. PubMed ID: 11822409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
